PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Mar 28, 2024 · 10-K · 88 days after period end · 0001140361-24-016265
| Metric | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$10.90M | -$19.14M | -$6.32M | -$4.03M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 28, 2024 · 88 d after period end
